0000899243-21-040751.txt : 20211020
0000899243-21-040751.hdr.sgml : 20211020
20211020161316
ACCESSION NUMBER: 0000899243-21-040751
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211018
FILED AS OF DATE: 20211020
DATE AS OF CHANGE: 20211020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pourhassan Nader
CENTRAL INDEX KEY: 0001532878
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49908
FILM NUMBER: 211334177
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytoDyn Inc.
CENTRAL INDEX KEY: 0001175680
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 753056237
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
BUSINESS PHONE: 360-980-8524
MAIL ADDRESS:
STREET 1: 1111 MAIN STREET, SUITE 660
CITY: VANCOUVER
STATE: WA
ZIP: 98660
FORMER COMPANY:
FORMER CONFORMED NAME: CYTODYN INC
DATE OF NAME CHANGE: 20031114
FORMER COMPANY:
FORMER CONFORMED NAME: REXRAY CORP
DATE OF NAME CHANGE: 20020617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-18
0
0001175680
CytoDyn Inc.
CYDY
0001532878
Pourhassan Nader
111 MAIN STREET, SUITE 660
VANCOUVER
WA
98660
1
1
0
0
President & CEO
Non-qualified Stock Option
1.39
2021-10-18
4
A
0
4275000
0.00
A
2031-10-18
Common Stock
4275000
4275000
D
The options will vest in 3 equal annual installments beginning on August 6, 2022, subject to Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.
Michael D. Mulholland, Attorney-In-Fact
2021-10-20